New infant vaccine aims to shield against three serious diseases
NCT ID NCT05091619
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This phase 3 study tests a new vaccine (DTacP) that protects infants from diphtheria, tetanus, and whooping cough. Around 2,900 healthy babies aged 2-3 months will receive the vaccine to check its safety and how well it triggers immunity. The trial compares different schedules and vaccine batches to ensure consistent protection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Diphtheria, tetanus, and acellular pertussis (three-component) combined vaccine (DTacP)
What this could lead to
If successful, this could provide a safe and effective option to protect infants from whooping cough, diphtheria, and tetanus.
What could go wrong
This is a late-stage trial, but results may vary by schedule or lot. Common vaccine side effects like fever or injection-site reactions are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TETANUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Neihuang County Center for Disease Control and Prevention
Anyang, Henan, 456300, China
-
Wen County Center for Disease Control and Prevention
Jiaozuo, Henan, 454850, China
-
Wuyang County Center for Disease Control and Prevention
Luohe, Henan, 462400, China
-
Yanjin County Center for Disease Control and Prevention
Xinxiang, Henan, 453200, China